Introducing RFP and GFP Antibodies by Rockland Immunochemicals

by | Nov 4, 2024 | Cancer, Immunology, Neurology, Organoids, Stem Cell, Virology

ANTIBODIES FROM ROCKLAND IMMUNOCHEMICALS

Introducing RFP antibodies and GFP antibodies from Rockland Immunochemicals

Rockland Immunochemicals’s RFP and GFP Antibodies category encompasses a comprehensive selection of antibodies targeting the widely utilized Green Fluorescent Protein (GFP) and Red Fluorescent Protein (RFP). These antibodies, produced through advanced development methods by experienced scientists, offer high specificity and reliability for diverse applications. From gene expression studies to protein localization, these antibodies are pivotal in tracking physiological processes and assessing transgenic or transient protein expression, providing essential tools for in vivo analysis. Explore more.

  • High specificity: Tailored to recognize native and variant forms of GFP and RFP
  • Versatile applications: Suitable for gene expression studies, protein localization, and more
  • Conjugation options: Available as HRP, biotin, AP, and fluorescent dye conjugates

ABOUT ROCKLAND IMMUNOCHEMICALS

60,000 square feet manufacturing facility with antibody and protein production capabilities

Established in 1962, Rockland is a global biotechnology company manufacturing leading-edge tools for basic, applied, and clinical research for academic, biopharma, diagnostic, and agbio industries. Rockland is a privately held company, operating manufacturing facilities with antibody and protein production capabilities near Philadelphia, Pennsylvania, USA. 

EXHAUSTED IN FINDING IDEAL ANTIBODIES?

Contact us
Share This